- Home
- DRRX vs VANI Comparison
DRRX vs VANI Comparison
Compare DRRX & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- VANI
- Stock Information
- Founded
- DRRX 1998
- VANI 1998
- Country
- DRRX United States
- VANI United States
- Employees
- DRRX N/A
- VANI N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DRRX Health Care
- VANI Health Care
- Exchange
- DRRX Nasdaq
- VANI Nasdaq
- Market Cap
- DRRX N/A
- VANI 75.2M
- IPO Year
- DRRX 2000
- VANI 2014
- Fundamental
- Price
- DRRX $0.61
- VANI $1.40
- Analyst Decision
- DRRX Hold
- VANI Strong Buy
- Analyst Count
- DRRX 1
- VANI 1
- Target Price
- DRRX N/A
- VANI $4.00
- AVG Volume (30 Days)
- DRRX 47.5K
- VANI 141.6K
- Earning Date
- DRRX 08-12-2025
- VANI 08-12-2025
- Dividend Yield
- DRRX N/A
- VANI N/A
- EPS Growth
- DRRX N/A
- VANI N/A
- EPS
- DRRX N/A
- VANI N/A
- Revenue
- DRRX $1,856,000.00
- VANI N/A
- Revenue This Year
- DRRX N/A
- VANI N/A
- Revenue Next Year
- DRRX $673.00
- VANI N/A
- P/E Ratio
- DRRX N/A
- VANI N/A
- Revenue Growth
- DRRX 79.84
- VANI N/A
- 52 Week Low
- DRRX $0.48
- VANI $0.91
- 52 Week High
- DRRX $1.74
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- DRRX 46.88
- VANI 74.26
- Support Level
- DRRX $0.57
- VANI $1.26
- Resistance Level
- DRRX $0.69
- VANI $1.30
- Average True Range (ATR)
- DRRX 0.06
- VANI 0.06
- MACD
- DRRX -0.00
- VANI 0.00
- Stochastic Oscillator
- DRRX 48.12
- VANI 69.70
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.